Aim: The purpose of this study was to analyze the hospitalization of diabetes mellitus patients in Polish hospitals in 2005-2009.

Materials And Methods: Data was taken from a nationwide database, kept at the National Institute of Public Health - National Institute of Hygiene in Warsaw. Data gathered for this work related to patients whose main cause of hospitalization was diabetes.

Results: In the period of five years the number of diabetes-caused hospitalizations increased by nearly 22% - from 172.2 per 100 thousand in 2005 to 209.9 per 100 thousand in 2009. Hospital treatment covered mainly patients suffering from type 2 diabetes (116.4 per 100 thousand in 2009), as well as type 1 diabetes (87.6 per 100 thousand in 2009). Patients under 39 years of age were more often hospitalized because of type 1 diabetes, whereas in the older age groups patients were more often treated in hospitals for type 2 diabetes. Generally, in both types of the disease, older patients required hospitalizations more often than the younger ones. Cardiovascular diseases were the most reported co-morbidity in both types of the disease. In 2005-2009 the hospital mortality rate decreased with regard to both types of diabetes and an average length of hospital stay decreased by one day, reaching 8.1 days in 2009.

Conclusion: It must be emphasized that the growing epidemic of diabetes and its complications are an important challenge to society. The percentage of people hospitalized due to diabetes is increasing every year and consumes significant resources dedicated to health care. Early diagnosis and appropriate treatment of diabetes are imperative, as well as reducing the disparities in access to medical care (ambulatory and stationary) for town and country residences.

Download full-text PDF

Source

Publication Analysis

Top Keywords

type diabetes
16
100 2009
12
diabetes
10
hospitalization diabetes
8
diabetes mellitus
8
mellitus patients
8
national institute
8
types disease
8
patients
7
analyses hospitalization
4

Similar Publications

A Review of Bavachinin and Its Derivatives as Multi-therapeutic Agents.

Chem Biodivers

January 2025

Gannan Medical University, Depatment of Medicinal Chemistry, Gannan Medical University, 341000, Ganzhou, CHINA.

Extracting natural active ingredients from plants is an effective way to develop and screen modern drugs. Psoralea corylifolia is a leguminous plant whose seeds have long been used as a Traditional Chinese Medicine to treat psoriasis, rheumatism, dermatitis, and other diseases. To date, several main compounds, including coumarins, flavonoids, monoterpene phenols, and benzofurans, have been identified from the seeds of Psoralea corylifolia.

View Article and Find Full Text PDF

Objective: We investigated associations between per- and polyfluoroalkyl substances (PFAS) and changes in diabetes indicators from pregnancy to 12 years after delivery among women with a history of gestational diabetes mellitus (GDM).

Research Design And Methods: Eighty Hispanic women with GDM history were followed from the third trimester of pregnancy to 12 years after delivery. Oral and intravenous glucose tolerance tests were conducted during follow-up.

View Article and Find Full Text PDF

Increasing evidence suggests that individuals infected with Coronavirus disease 2019 (COVID-19) are at a higher risk of developing type 2 diabetes (T2D) compared to those who are not infected. However, the mechanisms underlying this relationship remain poorly understood. In this study, we aimed to systematically evaluate the mediating roles of 3,283 plasma proteins in the link between COVID-19 susceptibility and T2D by conducting proteome-wide Mendelian randomization (MR) analyses.

View Article and Find Full Text PDF

Emerging Immunotherapies for Disease Modification of Type 1 Diabetes.

Drugs

January 2025

Division of Endocrinology, Department of Pediatrics, College of Medicine, University of Florida, 1699 SW 16th Ave, Building A, Gainesville, FL, 32608, USA.

Type 1 diabetes mellitus (T1DM) is characterized by the progressive, autoimmune-mediated destruction of β cells. As such, restoring immunoregulation early in the disease course is sought to retain endogenous insulin production. Nevertheless, in the more than 100 years since the discovery of insulin, treatment of T1DM has focused primarily on hormone replacement and glucose monitoring.

View Article and Find Full Text PDF

An insight on the additive impact of type 2 diabetes mellitus and nonalcoholic fatty liver disease on cardiovascular consequences.

Mol Biol Rep

January 2025

Department of Pharmaceutical Sciences & Technology, BIT Mesra, Ranchi, 835215, India.

Background: Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are associated with a multifactorial complicated aetiology that is often coexisting and has a strong and distinct connection with cardiovascular diseases (CVDs). In order to accomplish effective and appropriate therapeutic strategies, a deeper understanding of the bidirectional interaction between NAFLD patients, NAFLD patients with T2DM, and NAFLD patients with CVDs is required to control the concomitant rise in prevalence of these conditions worldwide. This article also aims to shed light on the epidemiology and mechanisms behind the relationship between T2DM, NAFLD and the related cardiovascular consequences.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!